MetLife Investment Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $304K | Sell |
|
|||||
|
2025
Q2 | $365K | Buy |
|
|||||
|
2025
Q1 | $193K | Sell |
|
|||||
|
2024
Q4 | $229K | Buy |
|
|||||
|
2024
Q3 | $232K | Sell |
|
|||||
|
2024
Q2 | $520K | Buy |
|
|||||
|
2024
Q1 | $370K | Sell |
|
|||||
|
2023
Q4 | $356K | Buy |
|
|||||
|
2023
Q3 | $98.8K | Hold |
|
|||||
|
2023
Q2 | $163K | Buy |
|
|||||
|
2023
Q1 | $30.8K | Sell |
|
|||||
|
2022
Q4 | $223K | Hold |
|
|||||
|
2022
Q3 | $219K | Buy |
|
|||||
|
2022
Q2 | $95.3K | Sell |
|
|||||
|
2022
Q1 | $187K | Buy |
|
|||||
|
2021
Q4 | $157K | Buy |
|
|||||
|
2021
Q3 | $162K | Sell |
|
|||||
|
2021
Q2 | $358K | Buy |
|
|||||
|
2021
Q1 | $336K | Hold |
|
|||||
|
2020
Q4 | $189K | Hold |
|
|||||
|
2020
Q3 | $98.1K | Hold |
|
|||||
|
2020
Q2 | $174K | Buy |
|